Home
Immix Biopharma IMMX paid Continental Strategy $105K for lobbying in Q2 2026 · Medical
Trade details
- Type
- Lobbying report
- Amount
- $105,000
- Quarter
- Q2 2026
- Stock
- Immix Biopharma IMMX
- Client
- Immix Biopharma
- Reported
- 26/07/19
Up 110.0% from last quarter
What else happened in Immix Biopharma around then
Filed or reported within 30 days of the trade day · 05/31~07/30Immix Biopharma's other lobbying reports
- Immix Biopharma
LobbyingImmix Biopharma
LobbyingImmix Biopharma
IMMX
$20K
$20K
Reported 07/20
for Q2
- Immix Biopharma
LobbyingImmix Biopharma
LobbyingImmix Biopharma
IMMX
$20K
$20K
Reported 07/17
for Q2
- Immix Biopharma
LobbyingImmix Biopharma
LobbyingImmix Biopharma
IMMX
$20K
$20K
Reported 04/20
for Q1
- Immix Biopharma
LobbyingImmix Biopharma
LobbyingImmix Biopharma
IMMX
$50K
$50K
Reported 04/20
for Q1